|
NOP58 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.388000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.624600E-01 |
| Normal-vs-Stage2 |
7.374000E-01 |
| Normal-vs-Stage3 |
2.196200E-02 |
| Normal-vs-Stage4 |
2.192000E-02 |
| Stage1-vs-Stage2 |
7.325000E-01 |
| Stage1-vs-Stage3 |
1.943610E-02 |
| Stage1-vs-Stage4 |
3.760300E-04 |
| Stage2-vs-Stage3 |
2.537600E-02 |
| Stage2-vs-Stage4 |
8.315100E-03 |
| Stage3-vs-Stage4 |
6.862800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.234400E-01 |
| Normal-vs-AfricanAmerican |
2.705000E-01 |
| Normal-vs-Asian |
2.159000E-01 |
| Caucasian-vs-AfricanAmerican |
4.593000E-01 |
| Caucasian-vs-Asian |
2.454000E-01 |
| AfricanAmerican-vs-Asian |
1.078000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.784000E-01 |
| Normal-vs-Female |
5.384000E-03 |
| Male-vs-Female |
2.697500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.785400E-01 |
| Normal-vs-Extreme_Weight |
9.860000E-01 |
| Normal-vs-Obese |
1.621970E-01 |
| Normal-vs-Extreme_Obese |
1.865210E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.898400E-01 |
| Normal_Weight-vs-Obese |
7.329400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.653500E-02 |
| Extreme_Weight-vs-Obese |
1.709230E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.632200E-01 |
| Obese-vs-Extreme_Obese |
4.111600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.143510E-02 |
| Normal-vs-Age(41-60Yrs) |
8.139700E-02 |
| Normal-vs-Age(61-80Yrs) |
5.113800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.817200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.906400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.461900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.440040E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.003940E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.743000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.771000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.687800E-01 |
| Normal-VS-Type2 PRCC |
7.578200E-01 |
| Normal-VS-KIRP CIMP |
1.838380E-03 |
| Normal-VS-Unclassified PRCC |
6.824800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.755800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.915490E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.928600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.378910E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.615400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.261400E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.393200E-01 |
| Normal-vs-N1 |
2.601000E-04 |
| Normal-vs-N2 |
4.409800E-01 |
| N0-vs-N1 |
8.04500000000097E-05 |
| N0-vs-N2 |
9.377600E-02 |
| N1-vs-N2 |
2.753600E-01 |
|
|
